Meridian Holdings (MRDN) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
The annual meeting is scheduled for October 7, 2024, with voting on board appointments and auditor ratification.
Proxy materials are distributed primarily online to reduce costs and environmental impact.
The company completed the acquisition of MeridianBet Group in April 2024, resulting in a reverse merger and recapitalization.
The board declassification and increase in authorized shares were approved and implemented in April 2024.
Voting matters and shareholder proposals
Shareholders will vote on the election of four directors (all voting shares) and one director (Series C Preferred only), and the ratification of M&K CPAS, PLLC as independent auditor.
Voting rights are allocated among common, Series B, and Series C Preferred Stock, with Series C holders having special board appointment rights.
Plurality voting applies for directors, and majority for auditor ratification; no cumulative voting is allowed.
Stockholder proposals for the 2025 meeting must be submitted by April 28, 2025, for proxy inclusion.
Board of directors and corporate governance
The board consists of five members, with a separate Chairman and CEO.
Board committees (Audit, Compensation, Nominating/Governance) are composed solely of independent directors.
The board diversity matrix shows one female and four male directors, with compliance to Nasdaq diversity rules.
Controlled company status applies, but the board voluntarily meets Nasdaq independence requirements.
Latest events from Meridian Holdings
- Record 21% revenue growth, debt down 59%, but $91.8M impairment drove net loss.MRDN
Q4 202531 Mar 2026 - Q3 2025 revenue rose 15% to $47.3M, profitability restored, and debt reduced.MRDN
Q3 202520 Mar 2026 - Q3 revenue up 85% to $41M, with strong growth from acquisitions and platform expansion.MRDN
Q3 20243 Feb 2026 - Q2 revenue surged 75% to $39.4M, with strong cash growth and Meridianbet integration.MRDN
Q2 20242 Feb 2026 - Record revenue growth and AI-driven expansion set the stage for strong 2025 outlook.MRDN
Q4 202426 Dec 2025 - Flexible $14.7M at-the-market stock offering supports growth but poses dilution risks.MRDN
Registration Filing16 Dec 2025 - $12M convertible note and warrants fund acquisitions but bring dilution and asset security risks.MRDN
Registration Filing16 Dec 2025 - Up to $14 million in common stock will be offered at-the-market for corporate and growth purposes.MRDN
Registration Filing16 Dec 2025 - Offering up to $14M in stock for growth and acquisitions, with notable dilution and market risks.MRDN
Registration Filing16 Dec 2025